Kawasaki disease: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
== Background ==
== Background ==
*Mucocutaneous lymph node syndrome
*Mucocutaneous lymph node syndrome
*Vasculitis of unknown etiology
*Vasculitis of unknown etiology
Line 6: Line 5:
**Rare in <4mo, >5yr
**Rare in <4mo, >5yr
*Leading cause of acquired heart disease in children
*Leading cause of acquired heart disease in children
*Coronary aneurysm more common in incomplete than in classic KD


 
==Diagnosis==
===Criteria===
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Classic Kawasaki Disease
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Classic Kawasaki Disease
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Incomplete Kawasaki Disease
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Incomplete Kawasaki Disease
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Fever for 5 d or more plus four of the following symptoms
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Fever for 5 d or more plus four of the following symptoms
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Fever for 5 d and two to three clinical criteria of classic Kawasaki disease
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Fever for 5 d and two to three clinical criteria of classic Kawasaki disease
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;1. Bilateral nonexudative conjunctivitis
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;1. Bilateral nonexudative conjunctivitis
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ''plus''&nbsp;
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''plus''&nbsp;
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;2. Mucous membrane changes (erythema, peeling, cracking of lips, "strawberry tongue," or diffuse oropharyngeal mucosae)
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;2. Mucous membrane changes (erythema, peeling, cracking of lips, "strawberry tongue," or diffuse oropharyngeal mucosae)
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | C-reactive protein&nbsp;[[Image:]]3.0 milligrams/L and/or erythrocyte sedimentation rate&nbsp;[[Image:]]40 mm/h plus three or more of the following supplemental labs or positive echo
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | C-reactive protein&nbsp;[[Image:]]3.0 milligrams/L and/or erythrocyte sedimentation rate&nbsp;[[Image:]]40 mm/h plus three or more of the following supplemental labs or positive echo
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="4" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;3. Changes of the extremities (erythema or swelling of hands/feet, peeling of finger tips/toes in the convalescent stage)
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="4" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;3. Changes of the extremities (erythema or swelling of hands/feet, peeling of finger tips/toes in the convalescent stage)
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;1. Albumin <3 grams/dL
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;1. Albumin <3 grams/dL
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;2. Anemia for age
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;2. Anemia for age
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;3. Elevated alanine aminotransferase
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;3. Elevated alanine aminotransferase
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;4. Platelets >450,000/mm<sup>3</sup>&nbsp;after 7 d of fever onset<br/>&nbsp;
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;4. Platelets >450,000/mm<sup>3</sup>&nbsp;after 7 d of fever onset<br/>&nbsp;
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;4. Rash
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;4. Rash
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;5. Cervical adenopathy (more than one node >1.5 cm unusually unilateral anterior cervical)
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;5. Cervical adenopathy (more than one node >1.5 cm unusually unilateral anterior cervical)
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;5. White blood cell count >12,000/mm<sup>3</sup><br/>&nbsp;
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;5. White blood cell count >12,000/mm<sup>3</sup><br/>&nbsp;
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | &nbsp;&nbsp;6. Presence of pyuria
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | &nbsp;&nbsp;6. Presence of pyuria
|}
|}
== Diagnosis ==
=== CDC Definition ===
*Fever >5d and 4 of the following:
#Rash
#Cervical LAD (>1.5cm diam, usually unilat)
#Bilateral nonexudative conjunctivitis
#Oral mucosal changes
#Extremity edema/erythema/desquamation
=== Presentation ===
=== Presentation ===
*Fever that is high, abrupt
*Fever that is high, abrupt
*Rash often seen in perineum; accompanies onset of fever
*Rash often seen in perineum; accompanies onset of fever
*Cardiac complications develop early on
*Cardiac complications develop early on
**Coronary artery aneurysm development most prevalent as fever lessens
**Coronary artery aneurysm development most prevalent as fever lessens


=== Associated Sx ===
=== Associated Sx ===
#Cardiac
#Cardiac
##Coronary aneurysm
##Coronary aneurysm
Line 81: Line 62:


== Work-Up ==
== Work-Up ==
#CBC/Diff/SPA/ALT/TBili
#CBC/Diff/SPA/ALT/TBili
#Blood Cx and UA
#Blood Cx and UA
#ECG
#ECG
#Echo (Coronaries, LV, Valves)
#TTE (Coronaries, LV, Valves)
#Red Top "Kawasaki Serum to CBR"
#Red Top "Kawasaki Serum to CBR"


== Treatment ==
== Treatment ==
 
#IVIG 2gm/kg over 12hr
#Immunoglobulin
##IVIG 2gm/kg over 12hr
#ASA 20mg/kg/dose q6h
#ASA 20mg/kg/dose q6h


== Disposition ==
== Disposition ==
 
#Admit
#Cardiology f/u
#Cont ASA at high dose
##Switch to ASA 3-5mg/kg/day once afebrile x48h


== Source ==
== Source ==
Tintinalli
Tintinalli


<br/>[[Category:Peds]] <br/><br/>
[[Category:Peds]]

Revision as of 18:21, 28 June 2011

Background

  • Mucocutaneous lymph node syndrome
  • Vasculitis of unknown etiology
  • Peaks at 18-24 months
    • Rare in <4mo, >5yr
  • Leading cause of acquired heart disease in children
  • Coronary aneurysm more common in incomplete than in classic KD

Diagnosis

Criteria

Classic Kawasaki Disease Incomplete Kawasaki Disease
Fever for 5 d or more plus four of the following symptoms Fever for 5 d and two to three clinical criteria of classic Kawasaki disease
  1. Bilateral nonexudative conjunctivitis plus 
  2. Mucous membrane changes (erythema, peeling, cracking of lips, "strawberry tongue," or diffuse oropharyngeal mucosae) C-reactive protein [[Image:]]3.0 milligrams/L and/or erythrocyte sedimentation rate [[Image:]]40 mm/h plus three or more of the following supplemental labs or positive echo
  3. Changes of the extremities (erythema or swelling of hands/feet, peeling of finger tips/toes in the convalescent stage)   1. Albumin <3 grams/dL
  2. Anemia for age
  3. Elevated alanine aminotransferase
  4. Platelets >450,000/mm3 after 7 d of fever onset
 
  4. Rash
  5. Cervical adenopathy (more than one node >1.5 cm unusually unilateral anterior cervical)   5. White blood cell count >12,000/mm3
 
  6. Presence of pyuria

Presentation

  • Fever that is high, abrupt
  • Rash often seen in perineum; accompanies onset of fever
  • Cardiac complications develop early on
    • Coronary artery aneurysm development most prevalent as fever lessens

Associated Sx

  1. Cardiac
    1. Coronary aneurysm
      1. Most develop during 3-4th week of illness
      2. May lead to MI (leading cause of death)
    2. Myo/pericarditis
    3. Pericardial effusion
    4. LV dysnfunction
    5. Valvular dysfunction
    6. Dysrhythmias
  2. Labs
    1. Elevated ESR/WBC/LFTs/Plts
  3. Aseptic meningitis
  4. Urethritis, Anemia
  5. RUQ pain, large GB (hydrops)

Work-Up

  1. CBC/Diff/SPA/ALT/TBili
  2. Blood Cx and UA
  3. ECG
  4. TTE (Coronaries, LV, Valves)
  5. Red Top "Kawasaki Serum to CBR"

Treatment

  1. IVIG 2gm/kg over 12hr
  2. ASA 20mg/kg/dose q6h

Disposition

  1. Admit

Source

Tintinalli